Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Doxorubicin-resistant MCF-7/ADR breast cancer cells
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics.
PubMed Full text in PMC Similar studies Analyze with GEO2R
Differences between CD44+/CD24- and CD44-/CD24+ subpopulation of immortalized human mammary epithelial cells
Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1
Cancer stem cell subpopulations within the CD44high human breast cancer stem cell compartment
Subpopulations of MDA-MB-231 and Primary Breast Cancers
Gene Expression Pattern in EP300 knocked-down MCF7 cells and corresponding paclitaxel resistant derivatives
Side population cells in human primary melanoma
RNA sequencing of Cd44-positive and Cd44-negative primary osteosarcoma isolated from Nf2 - mutant mice
PubMed Full text in PMC Similar studies
Expression data from breast cancer tumor-initiating cells
Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker
Gene Expression Profiles of Multiple Myeloma from the sorted SP/LC and CD138+ cells
CD24+ and CD24- myeloma-derived cancer stem cell lines
Ganglioside GD2 identifies Breast Cancer Stem Cells: Targeting GD3 Synthase Inhibits GD2 Expression and Tumor Growth
SAGE-Seq gene expression profiles of Hs578T, MCF7, and SUM159PT cells treated with STAT3 or non-targeting siRNAs, DMSO, or CXCR2, PTGIS, HAS1, PFKFB3, JAK, or NQO1 inhibitor
PubMed Full text in PMC Similar studies SRA Run Selector
The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression
Phenotypic plasticity determines cancer stem cell therapeutic resistance in oral squamous cell carcinoma II
Phenotypic plasticity determines cancer stem cell therapeutic resistance in oral squamous cell carcinoma I
Expression data from human mesenchymal stem cell and osteosarcoma cells
Suppression of poised oncogenes by ZMYND8 promotes chemo-sensitization
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on